|
Real-time Estimate
Cboe BZX
02:17:48 11/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 24.29 USD | -10.10% |
|
-8.01% | -12.63% |
| 12:48am | Wedbush Raises Price Target on Beam Therapeutics to $33 From $30, Keeps Outperform Rating | MT |
| 11:01pm | Beam Therapeutics Says Risto-Cel Meets Primary Endpoints in Sickle Cell Disease Trial | MT |
| Market Cap | 2.69B 2.42B 2.23B 2.02B 3.83B 252B 3.93B 26.65B 10.62B 135B 10.11B 9.89B 428B | P/E 2026 * |
-5.85x | P/E 2027 * | -5.22x |
|---|---|---|---|---|---|
| Enterprise Value | 1.8B 1.62B 1.49B 1.35B 2.56B 169B 2.63B 17.84B 7.11B 90.56B 6.77B 6.62B 286B | EV / Sales 2026 * |
46.8x | EV / Sales 2027 * | 68.7x |
| Free-Float |
98.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BEAM | Delayed | |
CBOE
| BEAM | Real-time | |
|
Mexican S.E.
| BEAM * | End-of-day quote |
Last Transcript: Beam Therapeutics Inc.
| 1 day | -10.12% | ||
| 1 week | -8.01% | ||
| Current month | -11.05% | ||
| 1 month | -3.62% | ||
| 3 months | -11.22% | ||
| 6 months | -23.72% | ||
| Current year | -12.63% |
| 1 week | 23.6 |  | 28 |
| 1 month | 23.16 | | 29.76 |
| Current year | 21.63 | | 38.26 |
| 1 year | 20.23 | | 38.26 |
| 3 years | 13.52 | | 49.5 |
| 5 years | 13.52 | | 95.46 |
| 10 years | 13 | | 138.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Evans
CEO | Chief Executive Officer | 48 | 01/01/2017 |
Sravan Emany
DFI | Director of Finance/CFO | 48 | 19/12/2024 |
| President | 57 | 24/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
John Evans
BRD | Director/Board Member | 48 | 01/01/2017 |
Mark Fishman
BRD | Director/Board Member | 75 | 01/05/2018 |
Graham Cooper
BRD | Director/Board Member | 56 | 10/10/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/10/26 | Exercice | Chief Executive Officer | 75,000 | 0.0726% | ||
| 1/10/26 | Sell | Controller/Auditor | -187 | 0.0002% | ||
| 24/9/26 | Don | Chairperson | -123,407 | 0.1195% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.10% | -8.01% | +11.87% | +9.30% | 2.69B | |
| +0.01% | +8.40% | +58.48% | +69.01% | 68.22B | |
| +1.22% | +9.56% | +15.97% | +90.23% | 59.82B | |
| +0.24% | +1.35% | +23.78% | +97.55% | 56.07B | |
| +0.99% | +18.38% | +27.66% | +111.07% | 47.67B | |
| -1.06% | +5.05% | +29.48% | +40.75% | 45.95B | |
| -4.61% | -1.92% | +203.68% | +866.51% | 43.29B | |
| -3.33% | +5.73% | +23.28% | +47.32% | 35.66B | |
| -2.19% | -3.71% | +90.94% | +66.33% | 34.73B | |
| +3.13% | +13.19% | -38.40% | +397.77% | 25.47B | |
| Average | -1.62% | +5.26% | +44.67% | +179.58% | 42B | |
| Weighted average by Cap. | -0.67% | +5.40% | +49.60% | +177.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.51M 34.53M 31.83M 28.9M 54.7M 3.61B 56.23M 381M 152M 1.93B 145M 141M 6.12B | 33.65M 30.18M 27.81M 25.26M 47.81M 3.16B 49.14M 333M 133M 1.69B 126M 124M 5.34B |
| Net income | -480M -431M -397M -361M -683M -45.05B -702M -4.75B -1.89B -24.14B -1.8B -1.76B -76.3B | -560M -502M -463M -420M -795M -52.49B -817M -5.54B -2.21B -28.12B -2.1B -2.06B -88.9B |
| Net Debt | -890M -798M -736M -668M -1.26B -83.46B -1.3B -8.81B -3.51B -44.72B -3.34B -3.27B -141B | -382M -343M -316M -287M -543M -35.85B -558M -3.78B -1.51B -19.21B -1.43B -1.4B -60.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | US$24.18 | -10.51% | 1,683,395 |
| 09/11/26 | US$27.02 | +2.31% | 1,292,254 |
| 06/11/26 | US$26.41 | +2.09% | 1,984,920 |
| 05/11/26 | US$25.87 | -6.91% | 2,991,345 |
| 04/11/26 | US$27.79 | +5.55% | 1,348,236 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
